PHASE I/IB PHARMACOKINETICS AND SAFETY STUDY OF IXAZOMIB IN MULTIPLE MYELOMA PATIENTS WITH SEVERE RENAL IMPAIRMENT/END-STAGE RENAL DISEASE REQUIRING HEMODIALYSIS (ESRD)
CLINICAL PHARMACOLOGY & THERAPEUTICS（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要